Floatz logo

SOMATROPIN RECOMBINANT

Disorder Of Fatty Acid And Ketone Body Metabolism

University of Aarhusprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Disorder Of Fatty Acid And Ketone Body Metabolism cohort.

Asset / SponsorPhaseRating
Ketone Monoester
University of Macau
N/AD

Same molecule, other indications

SOMATROPIN RECOMBINANT is also rated in:

isolated congenital growth hormone deficiencyActive
BBB
Indicative · Phase 4
77 / 100
View asset →
Prader-Willi syndromeActive
BBB
Indicative · Phase 4
77 / 100
View asset →
lipodystrophyDormant
BB
Indicative · Phase 4
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →